HIV-infected T-cell-derived miR-155–5p is transferred directly from HIV-1-infected T cells to cervical cancer cells via exosomes while activating the NF-κB signaling pathway by reducing the expression of its target gene ARID2, thus promoting the invasion of cervical cancer cells (Li J. et al., 2022). The gene discussed is ARID2; the disease is cervical carcinoma.